These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 21989940

  • 1. An optimized MM/PBSA virtual screening approach applied to an HIV-1 gp41 fusion peptide inhibitor.
    Venken T, Krnavek D, Münch J, Kirchhoff F, Henklein P, De Maeyer M, Voet A.
    Proteins; 2011 Nov; 79(11):3221-35. PubMed ID: 21989940
    [Abstract] [Full Text] [Related]

  • 2. Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
    Münch J, Ständker L, Adermann K, Schulz A, Schindler M, Chinnadurai R, Pöhlmann S, Chaipan C, Biet T, Peters T, Meyer B, Wilhelm D, Lu H, Jing W, Jiang S, Forssmann WG, Kirchhoff F.
    Cell; 2007 Apr 20; 129(2):263-75. PubMed ID: 17448989
    [Abstract] [Full Text] [Related]

  • 3. Development of resistance to VIR-353 with cross-resistance to the natural HIV-1 entry virus inhibitory peptide (VIRIP).
    Gonzalez E, Ballana E, Clotet B, Esté JA.
    AIDS; 2011 Aug 24; 25(13):1557-83. PubMed ID: 21572303
    [Abstract] [Full Text] [Related]

  • 4. Reduced Susceptibility to VIRIP-Based HIV-1 Entry Inhibitors Has a High Genetic Barrier and Severe Fitness Costs.
    Müller JA, Glöckle A, Gawanbacht A, Geyer M, Münch J, Kirchhoff F.
    J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925662
    [Abstract] [Full Text] [Related]

  • 5. Compensatory mutations rescue the virus replicative capacity of VIRIP-resistant HIV-1.
    González-Ortega E, Ballana E, Badia R, Clotet B, Esté JA.
    Antiviral Res; 2011 Dec 01; 92(3):479-83. PubMed ID: 22027647
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure.
    Pang W, Wang RR, Gao YD, Yang LM, Sun Y, Huang JF, Tien P, Zheng YT.
    J Biomol Screen; 2011 Feb 01; 16(2):221-9. PubMed ID: 21297108
    [Abstract] [Full Text] [Related]

  • 8. Amino acid derivatives of the (-) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1.
    An T, Ouyang W, Pan W, Guo D, Li J, Li L, Chen G, Yang J, Wu S, Tien P.
    Antiviral Res; 2012 Jun 01; 94(3):276-87. PubMed ID: 22426469
    [Abstract] [Full Text] [Related]

  • 9. A novel bispecific peptide HIV-1 fusion inhibitor targeting the N-terminal heptad repeat and fusion peptide domains in gp41.
    Jiang X, Jia Q, Lu L, Yu F, Zheng J, Shi W, Cai L, Jiang S, Liu K.
    Amino Acids; 2016 Dec 01; 48(12):2867-2873. PubMed ID: 27631437
    [Abstract] [Full Text] [Related]

  • 10. Protein design of a bacterially expressed HIV-1 gp41 fusion inhibitor.
    Deng Y, Zheng Q, Ketas TJ, Moore JP, Lu M.
    Biochemistry; 2007 Apr 10; 46(14):4360-9. PubMed ID: 17371053
    [Abstract] [Full Text] [Related]

  • 11. Fatty acids can substitute the HIV fusion peptide in lipid merging and fusion: an analogy between viral and palmitoylated eukaryotic fusion proteins.
    Lev N, Shai Y.
    J Mol Biol; 2007 Nov 16; 374(1):220-30. PubMed ID: 17919659
    [Abstract] [Full Text] [Related]

  • 12. X-ray crystallographic study of an HIV-1 fusion inhibitor with the gp41 S138A substitution.
    Watabe T, Terakawa Y, Watanabe K, Ohno H, Nakano H, Nakatsu T, Kato H, Izumi K, Kodama E, Matsuoka M, Kitaura K, Oishi S, Fujii N.
    J Mol Biol; 2009 Sep 25; 392(3):657-65. PubMed ID: 19616557
    [Abstract] [Full Text] [Related]

  • 13. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
    Danial M, van Dulmen TH, Aleksandrowicz J, Pötgens AJ, Klok HA.
    Bioconjug Chem; 2012 Aug 15; 23(8):1648-60. PubMed ID: 22770564
    [Abstract] [Full Text] [Related]

  • 14. Differential inhibition of HIV-1 and SIV envelope-mediated cell fusion by C34 peptides derived from the C-terminal heptad repeat of gp41 from diverse strains of HIV-1, HIV-2, and SIV.
    Gustchina E, Hummer G, Bewley CA, Clore GM.
    J Med Chem; 2005 Apr 21; 48(8):3036-44. PubMed ID: 15828842
    [Abstract] [Full Text] [Related]

  • 15. Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41.
    Soonthornsata B, Tian YS, Utachee P, Sapsutthipas S, Isarangkura-na-Ayuthaya P, Auwanit W, Takagi T, Ikuta K, Sawanpanyalert P, Kawashita N, Kameoka M.
    Virology; 2010 Sep 15; 405(1):157-64. PubMed ID: 20580393
    [Abstract] [Full Text] [Related]

  • 16. Molecular modeling of hair keratin/peptide complex: Using MM-PBSA calculations to describe experimental binding results.
    Azoia NG, Fernandes MM, Micaêlo NM, Soares CM, Cavaco-Paulo A.
    Proteins; 2012 May 15; 80(5):1409-17. PubMed ID: 22275089
    [Abstract] [Full Text] [Related]

  • 17. Computational study of bindings of HL9, a nonapeptide fragment of human lysozyme, to HIV-1 fusion protein gp41.
    Hartono YD, Lee AN, Lee-Huang S, Zhang D.
    Bioorg Med Chem Lett; 2011 Mar 15; 21(6):1607-11. PubMed ID: 21334893
    [Abstract] [Full Text] [Related]

  • 18. Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41.
    Liu S, Boyer-Chatenet L, Lu H, Jiang S.
    J Biomol Screen; 2003 Dec 15; 8(6):685-93. PubMed ID: 14711394
    [Abstract] [Full Text] [Related]

  • 19. Binding of antifusion peptides with HIVgp41 from molecular dynamics simulations: quantitative correlation with experiment.
    Strockbine B, Rizzo RC.
    Proteins; 2007 May 15; 67(3):630-42. PubMed ID: 17335007
    [Abstract] [Full Text] [Related]

  • 20. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
    Gallo SA, Sackett K, Rawat SS, Shai Y, Blumenthal R.
    J Mol Biol; 2004 Jun 25; 340(1):9-14. PubMed ID: 15184018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.